SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001564590-22-038976
Filing Date
2022-12-02
Accepted
2022-12-02 17:27:32
Documents
10
Effectiveness Date
2022-12-02

Document Format Files

Seq Description Document Type Size
1 S-3ASR 2022 axsm-s3asr.htm S-3ASR 873644
2 EX-4.7 axsm-ex47_164.htm EX-4.7 556775
3 EX-5.1 axsm-ex51_122.htm EX-5.1 33964
4 EX-5.2 axsm-ex52_123.htm EX-5.2 7981
5 EX-23.1 axsm-ex231_57.htm EX-23.1 6054
6 EX-FILING FEES axsm-exfilingfees_42.htm EX-FILING FEES 161816
7 GRAPHIC gvakwj2s0hvk000003.jpg GRAPHIC 5603
8 GRAPHIC gvakwj2s0hvk000001.jpg GRAPHIC 5603
9 GRAPHIC gvakwj2s0hvk000004.jpg GRAPHIC 5603
10 GRAPHIC gvakwj2s0hvk000002.jpg GRAPHIC 5603
  Complete submission text file 0001564590-22-038976.txt   1672727
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-268664 | Film No.: 221443109
SIC: 2834 Pharmaceutical Preparations